期刊文献+

四种聚酰胺-胺树状大分子制剂逆转人乳腺癌MCF-7/ADR细胞对阿霉素耐药性的研究

Research on the Resistance of Four Polyamidoamine Dendrimers Formulation in Reversing Human Breast Carcinoma MCF-7/ADR Cells to Adriacin
下载PDF
导出
摘要 目的探讨带有不同电荷及配体的树状大分子(PAMAM)对逆转人乳腺癌MCF-7/ADR细胞多药耐药(MDR)的影响。方法以阿霉素为模型药,比较了四种载药大分子(G 3.5/DOX,G 4.0/DOX,PEG-G 4.0/DOX,FA-G 4.0/DOX)对MCF-7/ADR细胞的细胞毒作用。结果四种大分子制剂的细胞毒均高于DOX溶液,FA-G 4.0(6.74μg/m L)最强,其逆转倍数达到5.07。与大分子制剂孵育2 h后,MCF-7/ADR细胞中阿霉素浓度大小为FA-G 4.0/DOX>G 4.0/DOX≈G 3.5/DOX>PEG-G 4.0/DOX>DOX溶液。结论四种大分子制剂均可一定程度地克服MCF/ADR细胞的耐药性,G3.5/DOX、G 4.0/DOX、PEG-G 4.0/DOX对MDR的影响没有显著区别,FA-G 4.0/DOX克服MDR的效果最好。 Objective To study the effect of dendrimers with different charges and ligands on the multidrug resistance of reversing human breast carcinoma MCF-7/ADR cells. Methods The cytotoxic effects of four drug loaded macromoleculars(G3.5/DOX, G 4.0/DOX, PEG-G 4.0/DOX, FA-G 4.0/DOX) on the MCF-7/ADR cell were compared by taking adriacin as model drugs. Results The cellular poison formulated by four macromoleculars was higher than DOX solution, and FA-G 4.0(6.74 μg/m L) was the strongest, and its reversal index reached 5.07, after 2h incubation of macromolecular formulation, the adriacin concentration in MCF-7/ADR cell was FA-G 〉4.0/DOX G 4.0/DOX ≈ G 3.5/DOX〉 PEG-G 4.0/DOX〉DOX solution. Conclusion Four macromolecular formulations can overcome the resistance of MCF/ADR cells to a certain degree,and there is no obvious difference in the effect of G 3.5/DOX, G 4.0/DOX, PEG-G 4.0/DOX on MDR, and the effect of FAG 4.0/DOX in overcoming MDR is the best.
作者 孙冬妮 牛垒
出处 《中国卫生产业》 2016年第24期115-117,共3页 China Health Industry
关键词 树状大分子 人乳腺癌耐阿霉素细胞 多药耐药 P-GP 叶酸靶向 Dendrimer Human breast cancer adriacin cell Multidrug resistance P-gp Folate-targeted
  • 相关文献

参考文献5

二级参考文献89

  • 1叶果,柯爱武,李羲.MRK-16修饰阿霉素免疫脂质体逆转肺癌细胞多药耐药研究[J].现代肿瘤医学,2007,15(6):754-757. 被引量:9
  • 2Robert J, Jarry C,Multidrug resistance reversal agents[J]. J Med Chem, 2003,46 (23) :4805-4817.
  • 3Poirier VJ, Thamm DH, Kurzman ID,et al. Liposomeencap- sulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats[J].J Vet Intern Med, 2002, ] 6 (6) : 726-731.
  • 4Fu L, Liang Y, Deng I., et al. Characterization of tetran- drine, a potent inhibitor of P-glyeoprotein-mediated multidrug resistance[J].2004,53(4) :349-356. Li X,Stuekert P,.
  • 5Bosch I, et al. Single-chain antibody-media ted gene delivery into ErbB 2-position human breast cancer cell[J]. Cancer Gene Ther, 2001,8(8) :555 -565.
  • 6Thierry AR,Vige D, Coughlin SS,et al. Modulation of doxo- rubicin resistance in multidrug resistant cells by liposomes[J]. FASEB J, 1993,7 (6) : 572-579.
  • 7Mamasheva, E, ODonnell C, Bandekar A,etal. Heterogene- ous liposome membranes with pH-triggered permeability en hanee the in witro antitumor activity of folate-receptor targeted liposomal doxorubicin[J].Mol Pharm, 2011,8 (6): 2224-2232.
  • 8Kang DI,Kang HK,Gwak HS. I.iposome composition is im portant for retention of liposomal rhodamine in P-glycoprotein overexpressing cancer cells[J]. Drug Deliv, 2009, 16(5): 26l-267.
  • 9Yuan F,Dellian M, Fukumura D, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size[J]. Cancer Res, 1995,55 (17) : 3752-3756.
  • 10Diao YY.Li HY.Fu YI-i.el al. Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and insracellular accu?mulation of doxorubicin in adriamycin-resistant tumor cells[n IntJ Nanomed.2011.6: 1955-1962.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部